Edgewise Therapeutics, Inc.
EWTX
$44.17
$0.992.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 460.71M | 499.56M | 530.11M | 563.34M | 593.99M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.45M | 10.23M | 13.28M | 10.56M | 9.26M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.36M | -- | -- | -- | -- |
| Total Current Assets | 471.52M | 509.79M | 543.39M | 573.90M | 603.26M |
|
|
|||||
| Total Current Assets | 471.52M | 509.79M | 543.39M | 573.90M | 603.26M |
| Net Property, Plant & Equipment | 8.17M | 8.73M | 9.22M | 9.57M | 10.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 479.69M | 518.52M | 552.60M | 583.47M | 613.33M |
|
|
|||||
| Total Accounts Payable | 4.67M | 7.29M | 6.01M | 6.16M | 8.32M |
| Total Accrued Expenses | 13.77M | 14.23M | 20.35M | 14.48M | 11.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.02M | 1.02M | 1.01M | 1.01M | 1.00M |
| Total Finance Division Other Current Liabilities | 9.59M | -- | -- | -- | -- |
| Total Other Current Liabilities | 9.59M | -- | -- | -- | -- |
| Total Current Liabilities | 29.04M | 22.54M | 27.37M | 21.65M | 20.90M |
|
|
|||||
| Total Current Liabilities | 29.04M | 22.54M | 27.37M | 21.65M | 20.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.57M | 2.78M | 2.98M | 3.17M | 3.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.61M | 25.32M | 30.35M | 24.82M | 24.26M |
|
|
|||||
| Common Stock & APIC | 1.10B | 1.09B | 1.07B | 1.05B | 1.04B |
| Retained Earnings | -652.71M | -595.38M | -546.37M | -496.16M | -455.49M |
| Treasury Stock & Other | -500.00K | -252.00K | 677.00K | 701.00K | 204.00K |
| Total Common Equity | 448.08M | 493.20M | 522.26M | 558.65M | 589.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 448.08M | 493.20M | 522.26M | 558.65M | 589.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 448.08M | 493.20M | 522.26M | 558.65M | 589.07M |
|
|
|||||